Hospitals and other medical facilities rely on 0.9% intravenous (IV) sodium chloride (normal saline) to treat dehydration and other problems.
The U.S. currently is experiencing a shortage of IV saline solution. The FDA says it is working with manufacturers of normal saline as the companies seek to restore their supply and is working with Fresenius Medical Care, which supplies normal saline to dialysis centers.
On its website, FDA noted that it “remains committed to doing everything it can to address this shortage. While FDA cannot require a manufacturer to produce a product, the agency will continue to use all the tools at its disposal to mitigate this and other drug shortages.”
Renal & Urology News would like to know to what extent, if any, the short of normal saline is impacting them, so please answer the following poll question. All poll responses are anonymous.